Published Date: 02 Mar 2023
The COVID-19 pandemic has highlighted the importance of vaccines in controlling the epidemic in sub-Saharan Africa and a renewed interest in vaccine research and development across the country.
Read Full NewsExplore anticipated FDA decisions on groundbreaking neurology drugs in 2026, shaping treatment options for various neurologic conditions.
As part of NeurologyLive®'s Year in Review, take a look at some of the top ongoing clinical trials in Alzheimer disease and dementia that may impact care.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 2, 2026.
Psychiatry in 2025: Year in Review
Gastroenterology in 2025: Year in Review
Weight-Adjusted Waist Index Predicts Cardiovascular Risk in Patients with T2D
1.
Check for eating disorders in bipolar disorder patients.
2.
Encounters matter in cancer care: Health care professionals can play a key role in restoring patients' sense of control
3.
Study Supports More Inclusive Clinical Trials With Broader Eligibility Criteria
4.
Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors
5.
Discovery of estrogen receptor 'switches' may aid breast cancer treatment
1.
Advancing Medical Oncology: Education, Certification, Clinical Trials, and Evolving Treatment Pathways
2.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
3.
Unveiling the Mysteries of Smudge Cells: A New Frontier in Cellular Biology
4.
Unlocking the Potential of Reticulocytes: The Key to Enhanced Blood Production
5.
The Unfolding Revolution of Precision Medicine, Immunotherapy, and Digital Transformation in Medical Oncology 2025
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part III
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
3.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
4.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation